10 Firms Drop on Bearish Statements, Disappointing Earnings

4. Tempus AI Inc. (TEM)

Tempus AI (TEM) fell by 13.81 percent on Monday to end at $32.34 each after fourth-quarter forecasts fell below Wall Street expectations.

In preliminary results released on Monday, the company said it expected revenues for the fourth quarter of the year to settle at $200 million, an increase of around 35 percent year-on-year. However, Wall Street analysts said they projected figures to settle at $205.7 million.

Tempus AI CEO Eric Lefkofsky said that genomics revenue is expected to rise by 30% in the fourth quarter, while data and services revenue is expected to be up 45%.

Tempus is an AI company focused on medicine and healthcare. In other news, it said that it was also developing its first whole-genome sequencing test.